Auburn unveils vaccine platform for intracellular pathogens

11/29/2012 | Opelika-Auburn News (Ala.)

Auburn University veterinary school researchers have designed a novel vaccine platform for intracellular pathogens such as malaria and tuberculosis. Both humans and animals can benefit from vaccines based on this research, but developing the veterinary vaccine first is most efficient, according to lead researcher and veterinarian Bernhard Kaltenboeck. "The veterinary route is going to produce a much quicker return on a lower investment, versus human vaccine, that takes much longer to produce a return and is a much higher investment," Kaltenboeck said.

View Full Article in:

Opelika-Auburn News (Ala.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ